Lifecore Biomedical, Inc. \De\ (LFCR) Gains from Investment Securities (2018 - 2020)

Lifecore Biomedical, Inc. \De\'s Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $500000.0 for Q1 2020.

• In Q1 2020, Gains from Investment Securities fell 80.77% year-over-year to $500000.0; the TTM figure through May 2021 stood at $500000.0 (changed N/A YoY), while the FY2020 annual figure was -$500000.0, up 85.71% from the prior year.
• Gains from Investment Securities for Q1 2020 stood at $500000.0, up from -$500000.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $2.6 million in Q1 2019, with the low at -$1.9 million in Q2 2018.
• The 3-year median for Gains from Investment Securities is $500000.0 (2020), against an average of $320000.0.
• The sharpest annual moves came in 2019 and 2020: Gains from Investment Securities sank 155.56% in 2019, then slumped 80.77% in 2020.
• Lifecore Biomedical, Inc. \De\'s Gains from Investment Securities stood at $900000.0 in 2018, then sank by 155.56% to -$500000.0 in 2019, then surged by 200.0% to $500000.0 in 2020.
• Business Quant data shows LFCR's Gains from Investment Securities at $500000.0 in Q1 2020, -$500000.0 in Q4 2019, and $2.6 million in Q1 2019.